查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1976687

醫療資產管理市場：依醫療設備、資訊科技基礎設施、設施管理、藥品和實驗室設備分類－2026-2032年全球預測

Healthcare Asset Management Market by Medical Equipment, Information Technology Infrastructure, Facilities Management, Pharmaceuticals, Laboratory Instruments - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療保健資產管理市場價值將達到 393.8 億美元，到 2026 年將成長至 428 億美元，到 2032 年將達到 776.1 億美元，複合年成長率為 10.17%。

主要市場統計數據
基準年 2025 393.8億美元
預計年份：2026年 428億美元
預測年份 2032 776.1億美元
複合年成長率 (%) 10.17%

醫療資產管理正經歷一場策略轉型，其驅動力來自多面向因素，包括技術加速應用、監管力度加大以及現有資本投資價值最大化的需求。管理影像設備、診斷儀器、藥品、 IT基礎設施和設施系統等各類資產的機構面臨雙重挑戰：既要維持臨床營運的連續性，又要整合新的數位化功能，以實現更有效率的預測性維護、遠端監控和使用情況追蹤。

隨著醫院和綜合醫療網路將韌性置於優先地位，它們正將工作重點從被動維護轉向基於生命週期的資產管治。這種轉變體現在對資產標籤、集中式資料平台以及整合採購、臨床工程和財務團隊的成熟管治流程的投資。這些變革並非自願，而是風險管理、實現臨床品質指標和控制營運成本的必要要素。此外，策略觀點如今已超越單一資產，涵蓋設備生態系統、軟體生態系統和設施網路。這種全面的觀點需要跨學科合作以及清晰的技術應用和人才培養藍圖。

數位化、不斷變化的法規、網路安全和人才動態都在匯聚，重新定義醫療保健資產管理的優先事項和營運模式。

醫療資產管理格局正在發生變化，這既帶來了機遇，也帶來了風險。數位化轉型是其中最顯著的驅動力。連網影像設備、具備分析功能的資產管理軟體以及雲端託管的IT基礎設施正在改變醫療機構監控資產狀態和分配資源的方式。這個數位化層面實現了遠距離診斷和預測性維護，但同時也擴大了網路安全威脅的攻擊面，並增加了透過臨床工程和IT安全部門之間的協作進行風險管理的必要性。

對 2025 年關稅措施將如何重塑整個醫療保健資產組合的採購經濟、備件策略和供應商本地化決策進行全面評估。

2025年實施的新關稅措施為醫療資產管理者在成本、供應鏈和策略採購方面帶來了複雜的挑戰。這些關稅措施影響成品醫療設備和中間組件，改變了影像設備、伺服器、網路設備、偵測設備以及某些藥品原料的採購經濟性。採購團隊現在需要權衡短期成本影響與供應商多元化、近岸外包和長期服務合約等策略優勢，這些措施可以保護機構免受關稅短期波動的影響。

明確醫療資產管理中的細分級別：使設備類型、 IT基礎設施、設施系統、藥品和實驗室設備與營運優先順序保持一致。

了解資產細分對於制定有針對性的資產管理策略至關重要，因為不同類型的資產在營運、維護和監管方面各有不同。以醫療設備為例，市場可細分為影像設備、病患監測系統及手術器材。影像設備可進一步細分為CT掃描儀及核磁共振造影系統，手術器械則可細分為一般手術器械及微創手術器械。每個細分市場都需要專門的維護通訊協定、校準週期和臨床使用規則。以資訊科技基礎設施為例，市場可細分為硬體、服務和軟體。硬體可再細分為網路設備和伺服器，軟體則可細分為分析軟體和資產管理軟體。這些細分有助於確定本地部署和雲端部署模式、修補程式更新頻率以及整合優先順序。

區域策略考量對資產管理的影響反映了全球市場供應鏈、管理體制和技術採用模式的多樣性。

區域環境影響資產策略，因為供應鏈、管理體制和臨床醫生工作流程因地區而異。在美洲，採購週期和報銷結構往往優先考慮快速採用先進的影像和監控技術，因此重點在於整合、運作保證和靈活的資金籌措。在歐洲、中東和非洲，監管協調、市場成熟度差異以及基礎設施的多樣性，催生了對模組化解決方案和多層服務模式的需求，這些方案和模式既適用於都市區三級醫療中心，也適用於農村醫療機構。在亞太地區，數位平台的快速普及、醫院容量的擴張以及本地生產能力的提升，正在加速對互聯IT基礎設施和設施自動化的投資。

供應商的產品藍圖、服務模式和管治實務如何決定醫療保健資產組合的長期價值和可靠性。

主要企業透過產品藍圖、服務模式和夥伴關係方式塑造資產管理生態系統，進而影響供應商的選擇。那些能夠整合強大的遠距離診斷功能、提供標準化互通性框架並承諾透明的生命週期支援合約的供應商，對於那些尋求在最大限度減少停機時間的同時獲取營運智慧的醫療系統而言，無疑是理想的策略合作夥伴。同樣重要的是，那些能夠將技術維護和分析能力相結合，從而實現預測性維護計劃的服務供應商，這有助於提高設備可用性並有效利用臨床資源。

採取切實可行、影響深遠的領導行動，整合管治、採購、技術和人才策略，以增強醫療保健資產的韌性和價值。

行業領導者必須將洞察轉化為可執行的步驟，以增強韌性並最佳化資產績效。首先，企業應採用生命週期管治模型，並利用統一的指標管理運轉率、使用率和合規性。此模型規範了資產標籤、文件和交接流程，確保在所有權變更和服務合約過渡期間的責任落實和資料完整性。

調查方法結合了現場訪談、技術文件和基於情境的供應鏈分析，以得出實用且檢驗的資產管理見解。

本研究整合了定性和定量數據，以得出平衡且實用的見解。主要資料來源包括對臨床技術人員、採購經理、醫院高階主管和供應商服務經理的訪談，旨在收集有關維護實務、備件物流和供應商績效的實際觀點。輔助資訊來源包括官方監管文件、醫療設備和IT系統技術標準、產業白皮書以及展示實施成果的案例研究。對主要和輔助資訊的交叉檢驗確保了結論既反映了實際情況，又符合既定標準。

一項強調生命週期管治、互操作系統和供應鏈彈性的全面分析，確保了醫療保健的連續性和營運績效。

總之，醫療資產管理正處於策略轉折點，技術創新、監管變革和供應鏈動態相互交織，重新定義了營運重點。未來發展需要各機構從各自獨立的維護實務轉向以生命週期為中心的管治，採用互通性的技術實現預測性獎勵，並實施使供應商激勵機制與臨床可用性一致的籌資策略。關稅相關的波動凸顯了多元化供應策略和透明的供應商合約對於保障醫療服務連續性的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備器材市場

  • 醫療影像設備
    • 電腦斷層掃描器（CT掃描儀）
    • 磁振造影（核磁共振造影系統）機
  • 病患監測系統
  • 手術器械
    • 一般外科器械
    • 微創手術器械

第9章：資訊科技基礎設施驅動的醫療保健資產管理市場

  • 硬體
    • 網路裝置
    • 伺服器
  • 服務
  • 軟體
    • 分析軟體
    • 資產管理軟體

第10章：按設施管理系統分類的醫療保健資產管理市場

  • 建築自動化
    • 空調系統
    • 照明控制系統
  • 家政
  • 安全系統
    • 門禁系統
    • 監控系統

第11章：按藥品類型分類的醫療保健資產管理市場

  • 生物製藥
    • 單株抗體
    • 重組蛋白
  • 品牌藥品
    • 循環系統藥物
    • 抗癌藥物
  • 學名藥

第12章：按實驗室設備分類的醫療保健資產管理市場

  • 分析設備
    • 層析法系統
    • 光譜分析儀
  • 生命科學設備
    • 細胞分析儀
    • PCR系統

第13章 醫療保健資產管理市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療保健資產管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫療保健資產管理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療保健資產管理市場

第17章：中國醫療資產管理市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Accruent, LLC
  • Baxter International Inc.
  • Cardinal Health, Inc.
  • GE HealthCare Technologies Inc.
  • International Business Machines Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Oracle Corporation
  • Securitas Healthcare, LLC
  • Sepio Inc.
  • Siemens Healthineers AG
  • Sonitor Technologies
  • SPM Assets by Planon Corporation
  • Vizzia Technologies
  • Zebra Technologies Corp.
Product Code: MRR-69324464D212

The Healthcare Asset Management Market was valued at USD 39.38 billion in 2025 and is projected to grow to USD 42.80 billion in 2026, with a CAGR of 10.17%, reaching USD 77.61 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 39.38 billion
Estimated Year [2026] USD 42.80 billion
Forecast Year [2032] USD 77.61 billion
CAGR (%) 10.17%

Healthcare asset management is undergoing a strategic reorientation driven by simultaneous pressures: accelerating technology adoption, heightened regulatory scrutiny, and the imperative to extract greater value from existing capital investments. Organizations that manage portfolios spanning imaging devices, laboratory instruments, pharmaceuticals, IT infrastructure, and facility systems are confronted with the dual challenge of sustaining uninterrupted clinical operations while integrating new digital capabilities that promise predictive maintenance, remote monitoring, and improved utilization tracking.

As hospitals and integrated delivery networks prioritize resilience, they are reallocating attention from reactive maintenance to lifecycle-based asset governance. This shift manifests through investments in asset tagging, centralized data platforms, and mature governance processes that align procurement, clinical engineering, and finance teams. These changes are not optional; rather, they are essential to manage risk, meet clinical quality metrics, and control operational costs. Moreover, the strategic lens now extends beyond individual assets to encompass networks of devices, software ecosystems, and facilities - a holistic view that requires cross-disciplinary collaboration and a clear roadmap for technology adoption and workforce development.

How digitalization, regulatory evolution, cybersecurity and workforce dynamics are jointly redefining priorities and operating models in healthcare asset management

The landscape of healthcare asset management is shifting in ways that reconfigure both opportunity and risk. Digital transformation is the most visible force: internet-connected imaging equipment, analytics-enabled asset management software, and cloud-hosted IT infrastructure are changing how organizations monitor asset health and allocate resources. This digital layer enables remote diagnostics and predictive maintenance, yet it also increases the attack surface for cybersecurity threats, intensifying the need for coordinated risk management across clinical engineering and IT security functions.

Concurrently, regulatory and compliance frameworks are evolving to reflect patient safety concerns and data privacy imperatives. Stricter standards for device interoperability, software validation, and supply chain transparency compel providers to document provenance and lifecycle events for critical assets. At the same time, workforce dynamics - including shortages in skilled biomedical technicians and new expectations for data literacy among frontline staff - are reshaping operational models. These transformative shifts require leaders to prioritize cross-functional training, invest in interoperable systems, and adopt rigorous vendor governance practices to ensure that technological gains translate into measurable improvements in uptime, patient safety, and fiscal stewardship.

Comprehensive assessment of how 2025 tariff actions are reshaping procurement economics, spare parts strategies and supplier localization decisions across healthcare assets

The introduction of new tariff measures in 2025 has created a complex overlay of cost, supply chain, and strategic sourcing considerations for healthcare asset managers. Tariffs affect both finished medical goods and intermediate components, altering procurement economics for imaging equipment, servers, networking hardware, laboratory instruments, and certain pharmaceutical inputs. Procurement teams must now weigh the immediate cost implications against the strategic benefits of supplier diversification, nearshoring, and long-term service agreements that insulate organizations from episodic tariff volatility.

Beyond procurement, tariffs have second-order effects on maintenance strategies and spare parts inventories. Facilities and clinical engineering departments are adjusting stocking policies to maintain clinical availability while avoiding excessive capital tied up in parts that risk obsolescence. In parallel, vendors are responding by revising distribution footprints, renegotiating service-level commitments, and localizing certain manufacturing processes. These responses create opportunities for healthcare organizations to renegotiate total-cost-of-ownership terms and to demand greater transparency in lifecycle support. Ultimately, asset managers must incorporate tariff scenarios into capital planning and vendor selection processes, ensuring continuity of care while preserving fiscal discipline and supplier accountability.

Segment-level clarity for healthcare asset management that aligns device types, IT infrastructure, facility systems, pharmaceuticals and laboratory equipment with operational priorities

Understanding segmentation is essential for targeted asset management strategies because assets exhibit distinct operational, maintenance, and regulatory profiles. Based on Medical Equipment, the market is studied across Imaging Equipment, Patient Monitoring Systems, and Surgical Instruments, with Imaging Equipment further examined through Computed Tomography Scanners and Magnetic Resonance Imaging Machines, and Surgical Instruments differentiated into General Surgical Instruments and Minimally Invasive Instruments; each subset requires tailored maintenance protocols, calibration cycles, and clinical utilization rules. Based on Information Technology Infrastructure, the market is studied across Hardware, Services, and Software, with Hardware further divided into Networking Equipment and Servers, and Software segmented into Analytics Software and Asset Management Software; these distinctions inform decisions about on-premises versus cloud deployments, patching cadences, and integration priorities.

In Facilities Management, the market is studied across Building Automation, Housekeeping, and Security Systems, with Building Automation further studied across HVAC Systems and Lighting Control Systems, and Security Systems distinguished into Access Control Systems and Surveillance Systems; these categories drive energy management initiatives and influence patient flow and safety protocols. Based on Pharmaceuticals, the market is studied across Biopharmaceuticals, Branded Drugs, and Generic Drugs, with Biopharmaceuticals further analyzed as Monoclonal Antibodies and Recombinant Proteins, and Branded Drugs examined through Cardiovascular Drugs and Oncology Drugs; pharmaceutical segmentation affects cold chain logistics, inventory turnover policies, and regulatory documentation. Based on Laboratory Instruments, the market is studied across Analytical Instruments and Life Science Instruments, with Analytical Instruments subdivided into Chromatography Systems and Spectroscopy Instruments, and Life Science Instruments including Cell Analysis Instruments and PCR Systems; laboratory segmentation determines calibration requirements, consumables planning, and biosafety considerations.

Recognizing these discrete segments enables asset managers to prioritize interventions that balance clinical impact, lifecycle costs, and regulatory compliance. It also facilitates procurement strategies that align vendor capabilities with specific asset-class requirements, thereby improving service reliability and reducing downstream operational friction.

Regional strategic considerations for asset management that reflect supply chain diversity, regulatory regimes and technology adoption patterns across global markets

Regional context shapes asset strategies because supply chains, regulatory regimes, and clinician workflows vary significantly across geographies. In the Americas, procurement cycles and reimbursement structures often prioritize rapid deployment of advanced imaging and monitoring technologies, which drives a focus on integration, uptime guarantees, and flexible financing. In Europe, Middle East & Africa, regulatory harmonization, diverse market maturities, and infrastructure variability create demand for modular solutions and multi-tiered service models that can be adapted to both urban tertiary centers and rural facilities. In Asia-Pacific, rapid adoption of digital platforms, expanding hospital capacity, and localized manufacturing capacities are accelerating investments in interconnected IT infrastructure and facility automation.

These regional distinctions mean that a one-size-fits-all approach to asset management is ineffective. Instead, organizations should adopt regionally differentiated procurement playbooks that account for vendor footprints, regulatory timelines, and the availability of technical talent. Moreover, capital planners should incorporate regional risk assessments - including political, trade, and logistical considerations - to ensure resilience. Ultimately, regional insights should inform vendor selection, spare parts strategies, and training programs so that the right mix of local support and centralized governance delivers consistent patient outcomes across diverse settings.

How vendor product roadmaps, service models and governance practices determine long-term value and reliability in healthcare asset portfolios

Key companies shape the asset management ecosystem through product roadmaps, service models, and partnership approaches that influence provider choices. Vendors that integrate robust remote diagnostics, offer standardized interoperability frameworks, and commit to transparent lifecycle support agreements stand out as strategic partners for healthcare systems aiming to minimize downtime while capturing operational intelligence. Equally important are service providers that can couple technical maintenance with analytics capabilities, enabling predictive maintenance programs that translate into higher equipment availability and more efficient utilization of clinical capacity.

In addition to product and service capabilities, vendor governance matters. Organizations should evaluate suppliers on criteria such as spare parts logistics, firmware and software update cadences, cybersecurity practices, and the availability of accredited field service engineers. Collaboration with vendors on data-sharing agreements and performance-based contracts can align incentives toward improved uptime and reduced total cost of care. Finally, companies that demonstrate commitment to workforce enablement and knowledge transfer - through training, certification, and remote support - will be better positioned to support long-term operational resilience and technology adoption across complex asset portfolios.

Practical, high-impact actions for leaders to align governance, procurement, technology and workforce strategies to strengthen healthcare asset resilience and value

Industry leaders must translate insights into executable actions that strengthen resilience and optimize asset performance. First, organizations should adopt a lifecycle governance model that integrates procurement, clinical engineering, finance, and IT under unified metrics for uptime, utilization, and compliance. This governance model should standardize asset tagging, documentation, and handoff processes so that accountability and data integrity persist across ownership changes and service contracts.

Second, leaders should prioritize investments in interoperable asset management software and analytics platforms that provide a single pane of glass for device health, maintenance scheduling, and spare parts forecasting. Such platforms enable predictive programs and reduce reactive maintenance workloads. Third, procurement strategies should shift toward total-cost-of-ownership contracts that include clear performance guarantees, defined spare parts availability, and penalties or credits tied to service outcomes. Fourth, workforce strategies must address technician shortages by investing in remote support capabilities, cross-training, and strategic partnerships with vendors for field service augmentation. Finally, leaders should incorporate geopolitical and tariff risk assessments into capital planning, diversifying suppliers and evaluating nearshoring options to preserve continuity of care while maintaining fiscal discipline.

Methodological approach that integrates frontline interviews, technical documentation and scenario-based supply chain analysis to produce practical and verifiable asset management insights

This research synthesizes qualitative and quantitative inputs to ensure balanced, actionable findings. Primary inputs include interviews with clinical engineers, procurement leaders, hospital operations executives, and vendor service managers to capture frontline perspectives on maintenance practices, spare parts logistics, and vendor performance. Secondary inputs comprise public regulatory documents, technical standards for medical devices and IT systems, industry white papers, and case studies demonstrating deployment outcomes. Cross-validation between primary and secondary sources ensures that conclusions reflect both lived operational realities and established standards.

Analytical methods emphasize triangulation and scenario analysis rather than predictive modeling. Asset-class analyses draw on device technical manuals, service-level agreements, and real-world service logs to identify common failure modes, maintenance cadences, and the interplay between software updates and device availability. For regional and tariff impact assessments, supply chain mapping and supplier footprint analysis were conducted to illustrate likely operational responses without relying on market sizing estimates. The methodology favors transparent assumptions, clearly documented data sources, and sensitivity checks to ensure that recommendations remain robust under varying operational conditions.

Concluding synthesis emphasizing lifecycle governance, interoperable systems and supply chain resilience to secure continuity of care and operational performance

In conclusion, healthcare asset management is at a strategic inflection point where technology, regulatory change, and supply chain dynamics converge to redefine operational priorities. The path forward requires organizations to move from siloed maintenance practices to lifecycle-centered governance, to adopt interoperable technologies that enable predictive maintenance, and to implement procurement strategies that align vendor incentives with clinical availability. Tariff-related disruptions underscore the importance of diversified supply strategies and transparent vendor agreements that protect continuity of care.

Leaders who act decisively will secure reliable clinical operations and extract greater value from existing assets by combining robust governance, targeted technology investments, and adaptive procurement practices. Sustained improvements will depend on collaborative relationships across clinical engineering, IT, procurement, and supplier partners, supported by consistent data practices and workforce development. By following the recommendations and frameworks presented in this report, organizations can strengthen readiness for emerging risks and capitalize on opportunities to enhance patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Asset Management Market, by Medical Equipment

  • 8.1. Imaging Equipment
    • 8.1.1. Computed Tomography Scanners
    • 8.1.2. Magnetic Resonance Imaging Machines
  • 8.2. Patient Monitoring Systems
  • 8.3. Surgical Instruments
    • 8.3.1. General Surgical Instruments
    • 8.3.2. Minimally Invasive Instruments

9. Healthcare Asset Management Market, by Information Technology Infrastructure

  • 9.1. Hardware
    • 9.1.1. Networking Equipment
    • 9.1.2. Servers
  • 9.2. Services
  • 9.3. Software
    • 9.3.1. Analytics Software
    • 9.3.2. Asset Management Software

10. Healthcare Asset Management Market, by Facilities Management

  • 10.1. Building Automation
    • 10.1.1. HVAC Systems
    • 10.1.2. Lighting Control Systems
  • 10.2. Housekeeping
  • 10.3. Security Systems
    • 10.3.1. Access Control Systems
    • 10.3.2. Surveillance Systems

11. Healthcare Asset Management Market, by Pharmaceuticals

  • 11.1. Biopharmaceuticals
    • 11.1.1. Monoclonal Antibodies
    • 11.1.2. Recombinant Proteins
  • 11.2. Branded Drugs
    • 11.2.1. Cardiovascular Drugs
    • 11.2.2. Oncology Drugs
  • 11.3. Generic Drugs

12. Healthcare Asset Management Market, by Laboratory Instruments

  • 12.1. Analytical Instruments
    • 12.1.1. Chromatography Systems
    • 12.1.2. Spectroscopy Instruments
  • 12.2. Life Science Instruments
    • 12.2.1. Cell Analysis Instruments
    • 12.2.2. PCR Systems

13. Healthcare Asset Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Healthcare Asset Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Healthcare Asset Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Healthcare Asset Management Market

17. China Healthcare Asset Management Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Accruent, LLC
  • 18.7. Baxter International Inc.
  • 18.8. Cardinal Health, Inc.
  • 18.9. GE HealthCare Technologies Inc.
  • 18.10. International Business Machines Corporation
  • 18.11. Koninklijke Philips N.V.
  • 18.12. McKesson Corporation
  • 18.13. Oracle Corporation
  • 18.14. Securitas Healthcare, LLC
  • 18.15. Sepio Inc.
  • 18.16. Siemens Healthineers AG
  • 18.17. Sonitor Technologies
  • 18.18. SPM Assets by Planon Corporation
  • 18.19. Vizzia Technologies
  • 18.20. Zebra Technologies Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 273. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 274. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 276. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIO